These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8544518)

  • 41. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 42. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL
    Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
    [No Abstract]   [Full Text] [Related]  

  • 43. Conversion from migraine without aura to typical aura without headache after irbesartan.
    Pinessi L; Ferrero M; Gentile S; Rainero I
    J Headache Pain; 2005 Apr; 6(2):100. PubMed ID: 16362652
    [No Abstract]   [Full Text] [Related]  

  • 44. Olmesartan induced enterocolitis.
    Gallivan C; Brown I
    Pathology; 2014 Jun; 46(4):360-1. PubMed ID: 24798161
    [No Abstract]   [Full Text] [Related]  

  • 45. Two coincident cases of easily curable 'refractory sprue'.
    Schiller D; Ziachehabi A; Silye R; Schöfl R
    Gut; 2015 Nov; 64(11):1714, 1773. PubMed ID: 25717152
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug-induced small-bowel mucosal atrophy.
    Santos-Antunes J; Coelho R; Cardoso H; Macedo G
    Endoscopy; 2015; 47 Suppl 1 UCTN():E8. PubMed ID: 25603525
    [No Abstract]   [Full Text] [Related]  

  • 47. Olmesartan-induced enteropathy resembling celiac disease.
    Khan AS; Peter S; Wilcox CM
    Endoscopy; 2014; 46 Suppl 1 UCTN():E97-8. PubMed ID: 24676835
    [No Abstract]   [Full Text] [Related]  

  • 48. Autoimmune-like chronic hepatitis induced by olmesartan.
    Barge S; Ziol M; Nault JC
    Hepatology; 2017 Dec; 66(6):2086-2088. PubMed ID: 28437842
    [No Abstract]   [Full Text] [Related]  

  • 49. Basophil activation in two cases of hydrochlorothiazide-induced noncardiogenic pulmonary edema.
    Manso L; Heili S; Fernández-Nieto M; Sastre B; Sastre J
    Allergy; 2010 Jan; 65(1):135-6. PubMed ID: 19804446
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar tablets.
    Williams RC; Alasandro MS; Fasone VL; Boucher RJ; Edwards JF
    J Pharm Biomed Anal; 1996 Aug; 14(11):1539-46. PubMed ID: 8877861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sprue-like enteropathy in the elderly treated with olmesartan].
    Calvo Beguería E; Martinez Huguet C; Gonzalez García MP; Omiste SanVicente T
    Rev Esp Geriatr Gerontol; 2017; 52(4):223-224. PubMed ID: 28277303
    [No Abstract]   [Full Text] [Related]  

  • 52. Olmesartan-associated enteropathy. A rare but easily treatable entity.
    Karakonstantis S; Tzagkarakis E; Giannikaki E; Paspatis G
    Acta Gastroenterol Belg; 2017; 80(4):541-543. PubMed ID: 29560654
    [No Abstract]   [Full Text] [Related]  

  • 53. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
    Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
    Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chronic diarrhea with easy solution, about 3 cases].
    Nadal-Máñez A; Casañ-Fernández R; Sanz-Gallur FJ; Cardona-Rovira MG
    Aten Primaria; 2019 Mar; 51(3):187-188. PubMed ID: 30617038
    [No Abstract]   [Full Text] [Related]  

  • 55. Gastrointestinal: Olmesartan-induced enteropathy.
    Shahzad MA; Harding D; Ruszkiewicz A; Tran E; England G; Philpott H
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1691. PubMed ID: 29968297
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
    Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
    Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic diarrhea and deep vein thrombosis during treatment with olmesartan.
    Gião Antunes A; Vaz AM; Cadillá J; Peixe B; Guerreiro H
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(2):200-202. PubMed ID: 28676194
    [No Abstract]   [Full Text] [Related]  

  • 58. Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea.
    Solano-Iturri G; García-Jiménez N; Solano-Iturri JD; Blanco-Sampascual S
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):71-72. PubMed ID: 28291561
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe olmesartan-induced sprue-like enteropathy with good corticosteroid treatment response.
    Alonso-Beato R; González-Pérez JA; Demelo-Rodríguez P
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(2):220-222. PubMed ID: 32192851
    [No Abstract]   [Full Text] [Related]  

  • 60. A Clinical Approach to Chronic Diarrhea.
    Dutra B; Siddiqui S; Everett J
    Gastroenterology; 2022 Mar; 162(3):707-709. PubMed ID: 34331913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.